SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-101476
Filing Date
2016-05-13
Accepted
2016-05-13 10:01:47
Documents
44
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v439065_10q.htm 10-Q 242337
2 CERTIFICATION v439065_ex31-1.htm EX-31.1 9634
3 CERTIFICATION v439065_ex31-2.htm EX-31.2 9591
4 CERTIFICATION v439065_ex32-1.htm EX-32.1 4511
5 CERTIFICATION v439065_ex32-2.htm EX-32.2 4302
  Complete submission text file 0001144204-16-101476.txt   2000086

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT casi-20160331.xml EX-101.INS 280529
7 XBRL TAXONOMY EXTENSION SCHEMA casi-20160331.xsd EX-101.SCH 26522
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE casi-20160331_cal.xml EX-101.CAL 20416
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE casi-20160331_def.xml EX-101.DEF 163248
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE casi-20160331_lab.xml EX-101.LAB 203207
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE casi-20160331_pre.xml EX-101.PRE 185619
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20713 | Film No.: 161646300
SIC: 2836 Biological Products, (No Diagnostic Substances)